Skip to content
Moojaz — موجز
Search
Menu
HomeRegionsMaghrebAfricaMiddle EastEuropeAsiaAmericasWorldSectionsPoliticsEconomySecurityHealthScienceTechnologyAIEnvironmentCultureSportsSearch
Event date: Reported information

Laprophan presents MAD 374 million sterile injectables plant

Published

Editorial principlesReport an error

During a press visit reported on 11 November 2026, Laprophan presented its subsidiary Amanys Pharma’s new sterile injectables facility in Aïn El Aouda, with an announced investment of MAD 374 million.

A bottle of saline solution.
Illustration, 2019: Fresenius product, not the cited factory. Pavel Dušek / Wikimedia Commons, CC BY 4.0 https://creativecommons.org/licenses/by/4.0/ ; unchanged. — Pavel Dušek / Wikimedia Commons — CC BY 4.0 https://creativecommons.org/licenses/by/4.0/ ; 20 octobre 2019, sans modification.

Announced capacity is about 30 million sale units a year. Médias24 places commissioning in the fourth quarter of 2027, while the MAP report refers more broadly to 2027.

The automated equipment covers filling, sterilisation and bottle inspection. These are industrial targets: the visit does not establish commercial production already achieved at that scale.

Sources 2